🔖
Bu Makaleye Atıf Yap
ÖZSOYLU, Ş. (2009). Treatment of primary myelofibrosis. Turkish Journal of Hematology, Cilt: 26 - Sayı: 4, 211–211. https://ajindex.com/articles/413014
Dergiler / Turkish Journal of Hematology / 2009 / Cilt: 26 - Sayı: 4
Treatment of primary myelofibrosis
- Sayfa
- 211–211
- DOI
- —
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗Kaynakça (1)
- Ozsoylu S, Ruacan S. High-dose intravenous corticosteroid treatment in childhood idiopathic myelofibrosis., Acta Haematol. 1986;75:49-51. 3. Ozsoylu S. High-dose intravenous methylprednisolone for idiopathic myelofibrosis, Lancet. 1988 Apr 2;1(8588):766. 4. Ozsoylu S. High-dose intravenous methylprednisolone in hematologic disorders., Hematology Res 1990;4:197-207. 5. Ozsoylu S, Ruacan S. Karaaslan Y. Dürdar S, Megadose intravenous methylprednisolone in adult myelofibrosis. Hematology Res 1991;5:121-8. 6. Han ZC, Briere I, Nedellec G, Abgrall JF, Sensebe L, Parent D, Guern G. Characteristics of circulating megalocyte progenitors (GFF-MK) in patients with primary myelofibrosis. Eur J Haematol 1988;40:130-5. 7. Pereira A, Cervantes F, Brugues R, Rozman C. Bone marrow histopathology in primary myelofibrosis: clinical and haematologic correlations and prognostic evaluation. Eur J Haematol. 1990 Feb;44:95-9.